European Technical Advisory Group of Experts on Immunization (‎ETAGE)‎ interim recommendations, June 2021: inclusion of adolescents aged 12–15 years in national COVID-19 vaccination programmes (2021)

At its adhoc meeting on 23 June 2021, ETAGE concurred with the Strategic Advisory Group of Experts’ advice that in the current situation of limited vaccine supply, countries should prioritize vaccination of populations at high risk of severe and fatal COVID-19 outcomes, including adolescents age 12–15 years, as well as those of 16–17 years of age, with underlying conditions and those who are in contact with vulnerable individuals. With increasing vaccine supply, more post-marketing vaccine safety data and high coverage in high-risk groups, countries may wish to consider vaccinating all adolescents age 12-15 years.